The acceptability of different lots of commercial components which constitute our basal medium for susceptibility testing of mycobacteria was evaluated. The basal medium consisted of Middlebrook 7H10 agar supplemented with 10% oleic acid-albumin-dextrose-catalase and 0.5% glycerol. Studies were performed by using three separate microbiologic assays, and results were compared with parallel tests on previously standardized and acceptable lots of media. Components were rejected if comparison with standardized medium showed a major change in growth support or susceptibility status of any reference strain to any antimicrobial agent tested. Of the components tested in such a manner, 7 of 23 (30%) lots of 10% oleic acid-albumindextrose-catalase, 2 of 13 (15%) lots of Middlebrook 7H10 agar, and 0 of 5 lots of glycerol were found to be unacceptable. This study demonstrates that individual lots of components of this basal medium may vary significantly in their suitability for susceptibility testing, and failure to detect such variation may dramatically affect susceptibility profiles.
Since the advent of effective antimycobacterial agents for the treatment of disease produced by the Mycobacterium tuberculosis complex, clinicians have been concerned about treatment failures. In spite of modern multiple-drug regimens, a small proportion of patients have persistent or recurrent disease because of the emergence of organisms that are resistant to antimicrobial agents (11) . Such organisms can also infect other individuals, causing primary drug resistance (13) . Therefore, drug susceptibility tests are performed to provide guidance in the selection of appropriate antimicrobial agents and to monitor the spread of resistant organisms. The procedures used in those tests must be standardized to produce consistent results, so that changes seen over time can be properly interpreted for individual patient management and for public health concerns. In the United States the susceptibility status of slowgrowing mycobacteria is commonly determined by comparing growth in drug-containing medium against growth in drug-free medium (7) . Using agar dilution or disk diffusion techniques, antimicrobial agents are incorporated into Middlebrook 7H10 agar supplemented with glycerol and a solution of oleic acid-albumin-dextrose-catalase (OADC) (5, 12) . In our early investigations, new lots of 7H10 agar base or supplements occasionally adversely affected the reproducibility of susceptibility test results. Since then, it has been our practice to monitor the incorporation of a new lot of any component into our standardized susceptibility procedures by performing parallel microbiologic assays. The results of these quality control studies over a 15-year period are the basis of this report.
MATERIALS AND METHODS
Strains. Reference cultures used in the quality control of medium components (7H10 agar, glycerol, OADC, drug solutions, and disks) for susceptibility studies on mycobacteria are listed in county and city public health laboratories in California. The isolates used in the following assays were chosen for their reproducible antibiograms; those used in assays on media containing drugs at or near diagnostic testing concentrations showed partial resistance during diagnostic testing or during searches for appropriate indicator strains among species not associated with disease. Individual stocks of these reference strains were maintained in Dubos-Tween-albumin broth at -700C.
Preparation of reference cultures. Reference cultures were grown in Dubos-Tween-albumin broth for 2 to 3 weeks or until turbidity reached a no. 1 McFarland standard. Broths were then vortexed (Deluxe Mixer; Baxter Scientific, Hayward, Calif.) for 5 min prior to filtration through Whatman no. 42 filter paper. Filtrates were stored at -700C in 1-ml amounts. Samples of the frozen suspensions were thawed and plated onto standardized medium to determine which dilution would subsequently yield approximately 100 to 200 CFU from a 0.1-ml volume.
Basal medium for susceptibility studies. The basal medium used in susceptibility tests and quality control studies consisted of 7H10 agar supplemented with 10% OADC and 0.5% glycerol (final concentration; vol/vol). Medium was dispensed in 5-ml quantities into individual sectors of a Felsen quadrant plate (X plate; Falcon; Becton Dickinson Labware, Oxnard, Calif.). Quadrant I contained only the basal medium, while quadrants Il through IV contained basal medium supplemented with a single antimicrobial agent either in a disk or in solution. Following solidification, plates were incubated at 35°C for 24 h to dry the agar surface and allow diffusion from any antimicrobial agent-impregnated disks. Plates for quality control studies were either used immediately after drying or held for a maximum of 14 days at 40C prior to use. Inoculated plates were incubated in 10% C02 in a mylar bag for 3 weeks at 350C before a final reading was taken.
Antimicrobial agents. Antimicrobial agents were combined with basal medium by mixing solutions into molten agar or by diffusion from antimicrobial agent-impregnated paper disks embedded in plated medium (8) . Solutions of powdered or crystalline antimicrobial agents were sterilized by filtration and sealed in serum bottles. All glassware used throughout preparation and storage were specially rinsed and soaked in hot distilled water. Solutions for large-volume drug media were prepared as concentrated aqueous solutions which were stored at 4°C and used during a 12-month period in a routine ratio of 1 ml/liter of medium; these solutions were 0.02 and 0.1% isoniazid, 0.2% p-aminosalicylic acid, and 0.2 and 1.0% streptomycin. Ethambutol in 0.5% aqueous solution was used at 1 and 2 ml/liter. Solutions for infrequently used drug media were prepared for the usual addition of 1 ml/ 100 ml of medium and were stored at -20°C in single-use vials; these solutions were 0.05% kanamycin and 0.1% capreomycin. Ethionamide was dissolved in ethylene glycol as a 0.5% solution, stored at 4°C, and added to medium in a routine ratio of 1 ml/liter of medium to minimize the volume of ethylene glycol incorporated into the final product. Samples of all of the solutions described above that were stored as indicated for 1 year showed comparable activities when tested in parallel with fresh solutions. Further details of our experience with drug stability will be presented in a separate report. Rifampin was solubilized in N,N-dimethylformamide as a 5% solution and diluted to 0.01% in distilled water at 50°C immediately before incorporation into medium in routine ratios of 1:100 and 5:100. All of the routine ratios of drug solutions to the medium specified above reflect usage in diagnostic testing, i.e., 0.2 and 1 ,ug of isoniazid per ml, 2 ,ug ofp-aminosalicylic acid per ml, 2 and 10 jLg of streptomycin per ml, 5 and 10 ,g of ethambutol per ml, 5 ,ug of kanamycin per ml, 10 ,ug of capreomycin per ml, 5 ,ug of ethionamide per ml, and 1 and 5 ,ug of rifampin per ml. Those Rejection criteria. Both sizes and number of colonies were considered in assessing the suitability of a new component for incorporation into standardized media. Colony sizes were graded as large, medium, small, and pinpoint; a reproducible change in two grades of colony size (e.g., from medium to pinpoint) was considered significant when standardized and test media in parallel quadrants were compared. Similarly, an average of a 20% or greater difference in the numbers of colonies was considered significant. In practice, minimum differences of two grades of size were often accompanied by at least a 20% change in numbers of colonies and vice versa, which made the observable differences more striking. When a significant difference was detected, fresh media were prepared for another comparison by using the same or another assay procedure, whichever seemed most appropriate; if the difference was confirmed, the component was rejected.
RESULTS
Over a 15-year period, 41 lots (OADC, n = 23; 7H10 base, n = 13; glycerol, n = 5) of individual medium components were evaluated for their suitability for use in susceptibility testing. By using the guidelines outlined above, nine lots (22%) were found to be unacceptable for one or more reasons ( Table 2) . Of the lots rejected, 7 were OADC (30% of the 23 OADC lots tested). A total of 2 of 13 lots of base and 0 of the 5 lots of glycerol tested during this study period were rejected. The most frequently encountered problems were reductions in the colony sizes of reference strains (Fig. 1) and the variable binding of antimicrobial agents, which led to the observation of either false susceptibility or false resistance (Fig. 2) .
The criteria used in the rejection of specific lots of OADC and 7H10 agar are listed in Table 2 . Six of the nine lots caused a marked reduction in the colony size of one or more reference cultures; six lots caused an alteration in the activity of one or more antimycobacterial agents with established MICs for control stains. Three lots, all OADC, produced both changes when compared with standardized basal medium.
DISCUSSION
Our early investigations on antimycobacterial drug stability revealed that apparent changes in drug activity are often more closely associated with new lots of components in the medium than with length or conditions of storage. Certain lots of 7H10 agar, OADC, and glycerol were found to produce results at variance with that for the control lot; therefore, they were rejected if they produced reduced colony sizes or numbers on drug-free medium or were diverted to the production of primary isolation media if they simply interfered with antimicrobial activity. Medium components were occasionally exchanged with cooperating laboratories; certain components were found to contribute to interlaboratory discrepancies. In one such exchange, base and OADC were each partially responsible for reportable differences. It is not surprising that variation in components could exhibit the broad range of effects reported here since other investigators have reported problems with a single drug (1, 2, 4) , and similar effects have been noted in susceptibility testing systems for other bacteria (6, 9, 10) .
The component with the greatest proportion of rejected lots was OADC, which, coincidentally, is purchased most often because it is a fluid and requires refrigeration, and its shelf life expires 2 years from the date of preparation. The effect of OADC on drug susceptibility studies was not related to a single manufacturer, control strain, or drug (Table 2) . Four different manufacturers of OADC supplied one or more unacceptable lots of this supplement. Similarly, eight isolates, representing five different species of mycobacteria, and all of the eight antimicrobial agents involved in these susceptibility tests were found to be affected by one or more unacceptable OADC lots. In one instance, the addition of OADC to the 7H10 base produced a noticeable opacity in the medium which interfered with reading. Variability in the reasons for rejection suggests that either different components within OADC may be individually or collectively causing problems or other contaminants associated with the production of this supplement may be at fault. Further work in determining which ingredients and combinations produce the observed variations and how the variations could be eliminated is warranted.
The valuable characteristics of mycobacterial susceptibility tests on 7H10 basal medium include an acceptable correlation of test results with clinical progress in an established system familiar to clinicians, the medium's ease of preparation, and the transparency of the medium, which facilitates microscopic examination of small colonies. (rifampin) . Before commercial availability, antimicrobial disks were supplied through the courtesy of Baltimore Biological Laboratories.
